Clinicians often use a medical test called a 12-lead electrocardiogram (ECG) to diagnose heart problems. It uses electrodes placed on the chest and limbs to record the heart's electrical activity. Artificial intelligence ...
3 hours ago
0
2
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a rare and progressive ...
Jul 9, 2025
0
17
Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of valve replacement, while ...
Jun 2, 2025
0
18
Despite scientific advances in cardiovascular care, people living in rural areas and other communities with long-term economic or social challenges still face barriers to cutting-edge therapies such as gene editing, according ...
May 28, 2025
0
9
Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complications due to its invasive nature. Researchers have now found a way to combine right ventricular ...
Feb 20, 2025
0
14
A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, according to research from UCL and the Royal Free Hospital.
Nov 19, 2024
0
26
Cardiac amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins. These amyloids can gather in different organs throughout the body, including the heart, liver ...
Nov 2, 2024
0
18
More people in the UK are at risk of a hereditary form of cardiac amyloidosis, a potentially fatal heart condition, than previously thought, according to a new study led by researchers at UCL (University College London) and ...
Aug 28, 2024
0
23
Physician–scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine have uncovered significant findings regarding the impact of transthyretin, or TTR, protein levels on heart disease risk.
Jul 29, 2024
0
39
AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death.
Jun 26, 2024
0
49
